Search clinical trials for: partial seizure disorder

Total 149135 results

Massachusetts General Hospital
Boston University; National Institute of Neurological Disorders and Stroke...

Recruiting

Sleep Spindles and Memory in Rolandic Epilepsy

Epilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of Childhood

United States
National Institute of Neurological Disorders and...

Recruiting

Investigating Epilepsy: Screening and Evaluation

Epilepsy | Seizures | Epilepsy, Temporal Lobe | Partial Epilepsy

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Malignant Glioma | WHO Grade 3 Glioma | Intractable Epilepsy | Seizure Disorder | WHO Grade 2 Glioma

United States
Marinus Pharmaceuticals

Completed

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 (0602)

Epilepsy, Complex Partial

United States
National Institute of Neurological Disorders and...

Terminated

Buspirone Therapy for Localized Epilepsy

Depression | Epilepsy | Seizures | Anxiety Disorder | Partial Epilepsy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pregabalin Versus Levetiracetam In Partial Seizures

Partial Seizures

Costa Rica, Spain, Greece, Korea, Republic of, Panama, Turkey, Philippines, Belgium, Taiwan, Germany, India, Italy, Colombia, Bulgaria, Russian Federation, France, Czechia, Lithuania, Mexico, Peru, Venezuela
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Once-A-Day Pregabalin For Partial Seizures

Epilepsies, Partial | Partial Seizures

United States, Singapore, Malaysia, Hungary, Czechia, India, Hong Kong, Mexico, Thailand, Argentina, Bosnia and Herzegovina, Bulgaria, Germany, Poland, Puerto Rico, Romania, Russian Federation, Serbia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Epilepsy | Epilepsies, Partial | Partial Seizure Disorder | Complex Partial Seizure Disorder

Costa Rica, Peru, El Salvador, Guatemala
National Institute of Neurological Disorders and...

Terminated

Evaluation and Treatment of Patients With Epilepsy

Epilepsy

United States
Children's Hospital of Philadelphia
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest

Seizures | Heart Arrest

United States
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Formulation of Pregabalin

Fibromyalgia | Diabetic Peripheral Neuropathy | Partial Seizure Disorder

Taiwan
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Partial Epilepsy in Children and Adolescents

United Kingdom, Spain, Serbia, Italy, Austria, Bosnia and Herzegovina, Croatia, Czechia, France, Germany, Hungary, Malaysia, Moldova, Republic of, Philippines, Poland, Portugal, Romania, Russian Federation, Slovakia, Taiwan, Ukr...
Novartis Pharmaceuticals

Completed

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures (EXIST-3)

Tuberous Sclerosis Complex-associated Refractory Seizures

United States, Colombia, Belgium, France, Japan, Taiwan, Turkey, Spain, Thailand, Korea, Republic of, Australia, Hungary, United Kingdom, Canada, Norway, Germany, Italy, Russian Federation, Denmark, Argentina, Netherlands, Greece, P... and more
Sunovion

Completed

Eslicarbazepine Acetate Monotherapy Long Term Study

Epilepsy

United States, Canada, Bulgaria, Ukraine, Czechia, Serbia
Children's Hospital Medical Center, Cincinnati
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (FIRST)

Benign Childhood Epilepsy With Centro-Temporal Spikes

United States
University of Pennsylvania
H. Lundbeck A/S

Terminated

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients (STARS)

Complex Partial Seizures

United States
National Institute of Neurological Disorders and...

Completed

Language and Emotional Function in Patients With Temporal Lobe Epilepsy

Epilepsy | Temporal Lobe

United States
National Institute of Neurological Disorders and...

Completed

Role of Hormones in Susceptibility to Seizures in Women With Epilepsy

Epilepsy

United States
National Institute of Neurological Disorders and...

Completed

Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

Epilepsy

United States
National Institute of Neurological Disorders and...

Completed

Electrical Brain Stimulation to Reduce Epileptic Seizures

Temporal Lobe Epilepsy

United States
National Institute of Neurological Disorders and...

Completed

Serotonin Receptors in Seizure Disorders

Partial Epilepsy

United States
National Institute of Neurological Disorders and...

Completed

MRI in Autosomal Dominant Partial Epilepsy With Auditory Features

Epilepsies, Partial

United States
Sunovion

Completed

Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

Epilepsy

United States, Bulgaria, Czech Republic, Serbia, Ukraine
Lundbeck LLC

Completed

Sabril Patient Registry

Infantile Spasms | Refractory Complex Partial Seizures in Adults
NeuroSigma, Inc.
Olive View-UCLA Education & Research Institute

Unknown

External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy (eTNS for DRE)

Seizure Disorder

United States
Sunovion

Completed

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Epilepsy With Simple or Complex Partial Onset Seizures

United States, Canada
Pfizer

Completed

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Seizure Disorder, Partial

Australia, Spain, Portugal, United Kingdom, Canada, Belgium, Germany, Poland, Netherlands, Austria
Eisai Inc.

Withdrawn

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Epilepsy, Partial
UCB Pharma

Completed

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (PASS)

Epilepsies, Partial

France, Germany, United Kingdom, Spain, Netherlands
Emory University
Baxter Healthcare Corporation

Terminated

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Seizure Disorder | Epilepsy, Partial | Epilepsy, Cryptogenic | Autoimmune Diseases, Nervous System | Limbic Encephalitis

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Epilepsy | Seizures | Partial Seizure Disorder

United States, Australia, France, Belgium, Taiwan, Spain, Argentina, Poland, India, Ukraine, Finland, Korea, Republic of, Russian Federation, Chile, Thailand, Hungary, Israel, New Zealand, Canada, Mexico, Norway, Netherlands, South...
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Epilepsy | Epilepsies, Partial | Epilepsy, Complex Partial | Complex Partial Seizures
Olive View-UCLA Education & Research Institute
Boston Scientific Corporation; Epilepsy Foundation

Completed

External Trigeminal Nerve Stimulation for Epilepsy

Epilepsy | Seizure Disorders

United States
SK Life Science, Inc.

Completed

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Epilepsy | Epilepsies, Partial
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Epilepsy | Epilepsies, Partial
SK Life Science, Inc.

Completed

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Epilepsy | Epilepsy, Complex Partial | Seizure Disorder | Complex Partial Seizures | Epilepsy, Focal
SK Life Science, Inc.

Completed

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Epilepsy | Epilepsy, Complex Partial | Seizure Disorder | Complex Partial Seizures | Epilepsy, Focal
Eisai Inc.

Completed

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

Epilepsy, Complex Partial

United States, Estonia, Ukraine, Hungary, Lithuania
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Epilepsy | Seizures
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Epilepsy | Seizures | Epilepsies, Partial
cerbomed GmbH

Completed

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Epilepsy

Germany
Pfizer

Completed

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Seizure Disorder, Partial

United States, Canada
Pfizer

Completed

A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

Epilepsies, Partial | Sleep Deprivation

Netherlands
National Institute of Neurological Disorders and...

Completed

Mapping the Areas of the Brain Associated With Language in Children With Epilepsy

Epilepsy | Seizures

United States
National Institute of Neurological Disorders and...

Completed

Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism

Epilepsy | Epilepsy, Complex Partial

United States

Search clinical trials for: partial seizure disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations